Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/27/2012US20120329733 Methods and products related to metabolic interactions in disease
12/27/2012US20120329731 Therapeutic methods, compositions, and compounds
12/27/2012US20120329730 Aromatic-cationic peptides and uses of same
12/27/2012US20120329729 Methods for treating diabetic foot ulcers
12/27/2012US20120329728 Compositions and methods for modulating gamma-c-cytokine activity
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329725 Chimeric Peptides for the Regulation of GTPases
12/27/2012US20120329724 Peptide analogues
12/27/2012US20120329723 Biological Agents Active in Central Nervous System
12/27/2012US20120329722 Method for enzymatically preparing peptides for use in improvement of brain function
12/27/2012US20120329721 Means for preventing and treating cellular death and their biological applications
12/27/2012US20120329720 Anti-inflammatory compounds and uses thereof
12/27/2012US20120329719 Methods of use of skin wound healing compositions
12/27/2012US20120329718 Compositions and methods for treating atrial fibrillation
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329716 Yellow pea seed protein-derived peptides
12/27/2012US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof
12/27/2012US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers
12/27/2012US20120329713 Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy
12/27/2012US20120329712 Induction of Differential Stress Resistance and Uses Thereof
12/27/2012US20120329711 Glp-1 receptor agonist compounds with a modified n-terminus
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329709 Production of glycoproteins
12/27/2012US20120329708 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329707 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329705 Compounds for proteasome enzyme inhibition
12/27/2012US20120329704 Process for the preparation of substituted prolyl peptides and similar peptidomimetics
12/27/2012US20120329703 Potent and Selective Mediators of Cholesterol Efflux
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329153 Car receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328700 Methods and compositions for regenerating connective tissue
12/27/2012US20120328699 Method and composition for treatment of skeletal dysplasias
12/27/2012US20120328693 Method for enhancing immune response in the treatment of infectious and malignant diseases
12/27/2012US20120328692 Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
12/27/2012US20120328691 Anilinopiperazine derivatives and methods of use thereof
12/27/2012US20120328690 Amniotic Membrane Preparations and Purified Compositions and Anti-Inflammation Methods
12/27/2012US20120328688 Biocompatible film with variable cross-sectional properties
12/27/2012US20120328684 Citrobacter freundii antibacterial agents and their use
12/27/2012US20120328676 Diketopiperazine salts for drug delivery and related methods
12/27/2012US20120328671 Composition
12/27/2012US20120328666 Oral delivery of peptide pharmaceutical compositions
12/27/2012US20120328665 Composite nanoparticle, and preparation process and use thereof
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328639 Immunogenic lhrh compositions and methods relating thereto
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328636 Kdr peptides and vaccines comprising the same
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328631 Ep1 inhibition
12/27/2012US20120328629 Therapeutic Applications Targeting SARM1
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia
12/27/2012US20120328611 Substituted triazolopyridines
12/27/2012US20120328610 Triazolopyridines
12/27/2012US20120328609 Modulation of Axon Degeneration
12/27/2012US20120328600 Injection of fibrin sealant using reconstituted components in spinal applications
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328596 Use of platelet activating factor acetylhydrolase as a biomarker for anaphylaxis
12/27/2012US20120328595 Variant activin receptor polypeptides and uses thereof
12/27/2012US20120328594 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
12/27/2012US20120328593 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012US20120328592 Stabilized alpha-galactosidase and uses thereof
12/27/2012US20120328591 Methods for improving oral delivery
12/27/2012US20120328589 Glucocerebrosidase multimers and uses thereof
12/27/2012US20120328585 Nutritional Composition Having Prebiotic
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328570 Hepatitis C Virus Inhibitors
12/27/2012US20120328569 Inhibitors of hepatitis c virus ns5b polymerase
12/27/2012US20120328568 Compositions and uses of lectins
12/27/2012US20120328567 Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereof
12/27/2012US20120328566 Estrogen receptor ligand treatment for neurodegenerative diseases
12/27/2012US20120328565 Antiviral compounds
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328562 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients
12/27/2012US20120328561 Method for treatment of inflammatory gastrointestinal disorders
12/27/2012US20120328560 Method for obtaining biologically active recombinant human g-csf
12/27/2012US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease
12/27/2012US20120328558 Antibody-light fusion products for cancer therapeutics
12/27/2012US20120328557 Adhesive cell tissue gels
12/27/2012US20120328539 Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent
12/27/2012US20120328527 Methods of enhancing functioning of the large intestine
12/27/2012US20120328526 Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
12/27/2012US20120328523 Polyhydroxyalkanoates for in vivo applications
12/27/2012US20120328520 Conjugate with target-finding ligand and use thereof
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012US20120328512 Fibrin-Binding Peptides and Conjugates Thereof
12/27/2012DE102004031579B4 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins, these nucleic acid molecule comprising, vector, host cell recognition molecule directed against these, these containing pharmaceutical composition containing them and their use kit
12/27/2012CA2840273A1 St6gal i mediated modulation of hematopoiesis
12/27/2012CA2840270A1 Methods of treating chronic disorders with complement inhibitors
12/27/2012CA2840113A1 An il-15 and il-15r.alpha. sushi domain based immunocytokines
12/27/2012CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
12/27/2012CA2839867A1 Glucagon/glp-1 receptor co-agonists
12/27/2012CA2839819A1 Hydrophobic polymer compound having anticoagulant effect
12/27/2012CA2839811A1 Materials and methods for modulating immune responses
12/27/2012CA2839686A1 Glucagon/glp-1 receptor co-agonists
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 3163